Serum Short‐Chain Fatty Acid Profiles as Metabolic Signatures of Diabetic Cognitive Impairment: Multinomial Modelling and Internally Validated Multiclass Discrimination

Key Points

• To identify serum short-chain fatty acid profiles as metabolic signatures of diabetic cognitive impairment (DCI).
• Utilized multinomial modelling for analysis.
• Evaluated serum samples for short-chain fatty acid profiles.
• Conducted internally validated multiclass discrimination studies.
• Identified specific short-chain fatty acids as biomarkers for DCI.
• Demonstrated effective discrimination between classes of cognitive impairment.